Cite
HARVARD Citation
Ungar, B. et al. (2017). Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab. Alimentary pharmacology & therapeutics. 45 (2), pp. 276-282. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ungar, B. et al. (2017). Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab. Alimentary pharmacology & therapeutics. 45 (2), pp. 276-282. [Online].